References
- Bohle A., Mackemsen S., Gise H. The consequence of tubulointerstitial changes for renal function in glomerulonephritis. Tubulointerstitial nephropathies, A Americo, P Cortelli, S Masry. Kluwer, Boston 1991; 29–40
- Thomas L., Fateh‐Moghadam A., Guder W. G., Hofmann W., Reiber H., Lammers M. Proteindiagnostik. 1981, Behring Diagnostika
- Jung K., Mattenheimer H., Burchardt U. Urinary enzymes. Springer, Berlin‐Heidelberg 1992
- Bradwell A. R., Mead G. P., Carr‐Smith H. D. Serum free light chain analysis. 2006, 4th edn. A. R. Bradwell, Birmingham
- Hofmann W., Garbrecht M., Bradwell A. R., Guder W. G. A new concept of Bence Jones proteinuria in patients with monoclonal gammopathy. Clin Lab 2004; 50: 181–5
- Evrin PE., Wibell L. Serum levels and urinary excretion of beta‐2‐microglobulin in apparently healthy subjects. Scand J Clin Lab Invest. 1972; 29: 69–74
- Hardwicke J. Laboratory aspects of proteinuria in human disease. Clin Nephrol 1975; 3: 37–41
- Balant L., Mulli J. C., Fabre J. Urinary Protein analysis with sodium dodecylsulfate polyacrylaminde gel electrophoresis ‐ a comparison with other analytical techniques. Clin Chim Acta 1973; 54: 27–37
- Hofmann W., Guder W. G. A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 1989; 27: 589–600
- Bernard A. M., Moreau D., Lauwerys R. Comparison of retinol binding protein and β2‐microglobulin determination in urine for the early detection of tubular proteinuria. Clin Chim Acta 1982; 126: 1–7
- Burchardt U., Haschen R. J., Krosch H. Clinical usefulness of enzyme determinations in urine. Diagnostic significance of enzymes and proteins in urine, U. C Dubach, U Schmidt. Hans Huber, Bern, Stuttgart, Vienna 1979; 106–11
- Everaert K., Delange I., Vade Wide C., et al. The urinary α1‐microglobulin: Its measurement and clinical significance. J Clin Lab Med 1998; 36: 309–15
- Bernard A. M., Thielemans N. O., Lauwerys R. R. Urinary protein 1 or Clara cell protein: a new sensitive marker of proximal tubular dysfunction. Kidney Int 1994; 46 Suppl 47: 34–7
- Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., et al. Identification of neutrophil gelatinase‐associated lipocalin as a novel early urinary biomarker for ischemic renal injury. 2003; 14: 2534–43
- Vaidya V. S., Ramiez V., Ichimura T., Bobadilla N. A., Bonventre J. V. Urinary kidney injury molecule‐1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006; 290: 517–29
- Itoh Y., Kawai T. Human α1‐microglobulin: Its measurement and clinical significance. J Clin Lab Anal 1990; 4: 376–84
- Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38: 20–7
- Herget‐Rosenthal H., Poppen D., Hüsing J., Marggraf G., Pietruck F., Jacob H‐G., et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50: 552–8
- Branten A., du Buf‐Vereijken P. W., Klasen I. S., Bosch F. H., Feith G. W., Hollander D. A., et al. Urinary excretion of ß2‐microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J Am Soc Nephrol 2005; 16: 169–74
- Hofmann W., Edel H., Guder W. G. A mathematical equation to differentiate overload proteinuria from tubulo‐interstitial involvement in glomerular diseases. Clin Nephrol 1995; 44: 28–81
- Guder W. G., Hofmann W. Challenges in urine analysis and glomerular filtration measurement for early detection of kidney diseases. Farm Vestn (Pharm J Slovenia) 2004; 55: 285–6
- Guder W. G., Hofmann W. Urine α1‐microglobulin as a predictive marker to differentiate diabetic nephropathy from other causes of albuminuria. Euromedlab Barcelona. Clin Chem Lab Med 2003; 41: 253 [abstract]
- Hofmann W., Ruth D., Guder W. G. Urine protein differentiation and Protis, a new expert system for its interpretation. Riv Med Lab‐JLM 2003; 4: 67–8
- Kouri T., Fogazzi G., Gant V., Hallander H., Hofmann W., Guder W. G. European Urinalysis Guidelines. Scand J Clin Lab Invest 2000; 60 Suppl 231